Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Syncollin
, a novel pancreatic zymogen granule protein, is present on the luminal side of the granule membrane. To address the function of
syncollin
, we searched for putative binding partners. Cross-linking experiments with purified
syncollin
, and granule content and membrane proteins revealed a direct interaction between
syncollin
and GP-2, a major glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. An interaction was also observed when cross-linking was performed with recombinant GP-2. In addition,
syncollin
could be cross-linked to itself, supporting the suggestion that it exists as a homo-oligomer. Cleavage of the GPI anchor of GP-2 by treatment of granule membranes with phosphatidylinositol-specific
phospholipase C
had no effect on the membrane attachment of
syncollin
, indicating that it is not mediated exclusively via an interaction with GP-2.
Syncollin
was found to be associated with detergent-insoluble cholesterol/glycolipid-enriched complexes. These complexes floated to the lighter fractions of sucrose-density gradients and also contained GP-2, the lectin ZG16p, sulphated matrix proteoglycans and the soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors (SNAREs) syntaxin 3 and synaptobrevin 2. Our results indicate that membrane-associated
syncollin
is a component of lipid rafts, where it interacts both with GP-2 and membrane lipids. We suggest that the
syncollin
-GP-2 complex might play a role in signal transduction across the granule membrane.
...
PMID:Interaction of syncollin with GP-2, the major membrane protein of pancreatic zymogen granules, and association with lipid microdomains. 1185 52